Zamboni, William C.
University of North Carolina at Chapel Hill
6 papers on CoChatORCID 0000-0002-8319-4482
Most cited papers
- Verified
Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity
Wallace, B. D., Roberts, A. B., Pollet, R. M., Ingle, J. D., Biernat, K. A., Pellock, S. J., Venkatesh, M. K., Guthrie, L., O’Neal, S. K., Robinson, S. J., et al. (2015) · Chemistry & Biology
Enzyme Structure and FunctionPharmacogenetics and Drug Metabolism
Cited by 285
- Verified
Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy
Roberts, P. J., Bisi, J. E., Strum, J. C., Combest, A. J., Darr, D. B., Usary, J. E., Zamboni, W. C., Wong, K.-K., Perou, C. M., & Sharpless, N. E. (2012) · JNCI Journal of the National Cancer Institute
Advanced Breast Cancer TherapiesCancer-related Molecular Pathways
Cited by 255
- Verified
A reanalysis of nanoparticle tumor delivery using classical pharmacokinetic metrics
Price, L. S. L., Stern, S. T., Deal, A. M., Kabanov, A. V., & Zamboni, W. C. (2020) · Science Advances
Nanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery
Cited by 128
- Verified
Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity
Hwang, D., Dismuke, T., Tikunov, A., Rosen, E. P., Kagel, J. R., Ramsey, J. D., Lim, C., Zamboni, W., Kabanov, A. V., Gershon, T. R., et al. (2021) · Nanomedicine: Nanotechnology, Biology and Medicine
Nanoparticle-Based Drug DeliveryGlioma Diagnosis and Treatment
Cited by 53
- Verified
Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist’s Perspective
Lucas, A. T., Moody, A., Schorzman, A. N., & Zamboni, W. C. (2021) · Antibodies
Monoclonal and Polyclonal Antibodies ResearchToxin Mechanisms and Immunotoxins
Cited by 40
- Verified
Summary report of PQRI workshop on nanomaterial in drug products: current experience and management of potential risks
Bartlett, J. A., Brewster, M., Brown, P., Cabral-Lilly, D., Cruz, C. N., David, R., Eickhoff, W. M., Haubenreisser, S., Jacobs, A., Malinoski, F., et al. (2015) · The AAPS Journal
Nanoparticle-Based Drug DeliveryNanotechnology research and applications
Cited by 25
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free